|
|
Prepublished online as a Blood First Edition Paper on July 10, 2003; DOI 10.1182/blood-2003-05-1681.

Submitted May 27, 2003
Accepted June 30, 2003
Persistent -globin expression in adult transgenic mice by HPFH-2, HPFH-3 and HPFH-6 breakpoint sequences
Eleni Z Katsantoni, An Langeveld, Albert W K Wai, Dubravka Drabek, Frank Grosveld, Nicholas P Anagnou, and John Strouboulis*
Department of Basic Sciences, University of Crete School of Medicine, Heraklion, Greece
Institute of Molecular Biology and Biotechnology, Heraklion, Greece
Department of Basic Sciences, University of Athens School of Medicine, Athens, Greece
Department of Cell Biology and Genetics, Erasmus Medical Center, Rotterdam, The Netherlands
* Corresponding author; email: i.strouboulis{at}erasmusmc.nl.
Deletions at the 3' end of the human -globin locus are associated with the hereditary persistence of fetal hemoglobin (HPFH) in adults, potentially through the juxtaposition of enhancer elements in the vicinity of the fetal -globin genes. We have tested how sequences at the HPFH-2, HPFH-3 and HPFH-6 breakpoints, which act as enhancers in vitro, affect the silencing of an LCRA transgene in the adult stage of mice. We found persistent A expression in the adult blood of most of the multi-copy HPFH-2, HPFH-3 or HPFH-6 lines, in contrast to the control LCRA lines which were silenced. Cre-mediated generation of single copy lines showed persistent gene expression maintained in some of the HPFH-2 and HPFH-6 lines, but not in any of the HPFH-3 or LCRA lines. In the HPFH-2 and HPFH-6 lines, persistent gene expression correlated with euchromatic transgene integrations. Thus, our observations provide support for a model whereby HPFH conditions arise from the juxtaposition of enhancers as well as permissive chromatin subdomains in the vicinity of the -globin genes.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
P. Moi and M. Sadelain
Towards the genetic treatment of {beta}-thalassemia: new disease models, new vectors, new cells
Haematologica,
March 1, 2008;
93(3):
325 - 330.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Gazouli, E. Katsantoni, T. Kosteas, and N. P. Anagnou
Persistent Human {gamma}-Globin Expression in Adult Transgenic Mice Following Selective Deletion of Two Repressor Elements Located 3' to the A{gamma}-Globin Gene.
Blood (ASH Annual Meeting Abstracts),
November 16, 2006;
108(11):
1585 - 1585.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Bank
Regulation of human fetal hemoglobin: new players, new complexities
Blood,
January 15, 2006;
107(2):
435 - 443.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Xiang, H. Han, G. Barkess, I. Olave, X. Fang, W. Yin, G. Stamatoyannopoulos, and Q. Li
Juxtaposition of the HPFH2 enhancer is not sufficient to reactivate the {gamma}-globin gene in adult erythropoiesis
Hum. Mol. Genet.,
October 15, 2005;
14(20):
3047 - 3056.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Chakalova, C. S. Osborne, Y.-F. Dai, B. Goyenechea, A. Metaxotou-Mavromati, A. Kattamis, C. Kattamis, and P. Fraser
The Corfu {delta}{beta} thalassemia deletion disrupts {gamma}-globin gene silencing and reveals post-transcriptional regulation of HbF expression
Blood,
March 1, 2005;
105(5):
2154 - 2160.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Xiang, X. Ye, H. Han, M. Stafford, S. George, and Q. Li
Juxtaposition of the HPFH2 Enhancer Is Not Sufficient To Reactivate the g-Globin Gene in Adult Erythropoiesis in bYAC Transgenic Mice.
Blood (ASH Annual Meeting Abstracts),
November 16, 2004;
104(11):
1215 - 1215.
[Abstract]
|
 |
|
|
|